7 Must-Read Stories In March 2019

Stories about outstanding scientists topped the charts in the month of March, but readers were also curious about feats of engineering and studies about diseases.

Zika Virus Endemic In Thailand, Study Shows

Unlike in South America where the Zika virus disappears two or three years after outbreaks, Zika transmission in Thailand has persisted for at least 16 years.

Takeda Establishes Center Of Excellence In Singapore

Takeda Pharmaceuticals has entered into a multi-year partnership with the Singapore Economic Development Board to support the recruitment and training of local talent for vaccine process optimization.

7 Must-Read Stories In February 2018

February saw the successful cloning of monkeys, intercontinental quantum communication and the fast tracking of a Zika vaccine candidate.

Takeda’s Zika Vaccine Moves Into The Fast Lane

TAK-426, Takeda’s Zika vaccine currently in phase 1 trials, has received US Food and Drug Administration’s Fast Track designation.

7 Must-Read Stories In September 2016

Whether it's self-driving cabs or university rankings, stories about Singapore were popular in September.

Subject: Zika, OMG

If you were emailing your friends about the Zika outbreak as it unfolded, it might looked something like this.

Zika Test By Singapore Firm Receives FDA Emergency Use Authorization

A Zika test developed by Singapore-based Vela Diagnostics has received Emergency Use Authorization for use in the United States.

These Countries Are At Greatest Risk Of Zika, Study Shows

India, China, the Philippines, Indonesia, Nigeria, Vietnam, Pakistan, and Bangladesh are expected to be at greatest risk of Zika virus transmission because of their limited health resources.

Takeda To Develop Zika Vaccine With $19.8m BARDA Funding

The US$19.8 million initial funding will cover the development of a Zika vaccine through to a Phase I clinical trial.